Bio-Rad Laboratories BIO Debt Repayments
Debt Repayments at other companies
Other financials
Where this comes from
Reported directly by Bio-Rad Laboratories in its filing.
Tagged under the XBRL concept us-gaap:RepaymentsOfLongTermDebt.
The official record: Bio-Rad Laboratories’s 10-Q, filed April 30, 2026, on SEC EDGAR. View the filing →
Ask your AI about Bio-Rad Laboratories's debt repayments.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Bio-Rad Laboratories's debt repayments?
- Bio-Rad Laboratories (BIO) reported debt repayments of $100K in Q1 2026.
- How has Bio-Rad Laboratories's debt repayments changed year-over-year?
- Bio-Rad Laboratories's debt repayments decreased by 0.0% year-over-year, from $100K to $100K.
- What is the long-term trend for Bio-Rad Laboratories's debt repayments?
- Over 4 years (2021 to 2025), Bio-Rad Laboratories's debt repayments has grown at a -36.2% compound annual growth rate (CAGR), from $3.02M to $500K.
- What does debt repayments mean?
- Cash used to pay down the principal amount of borrowed debt.
- How do you interpret debt repayments?
- Higher repayment amounts indicate a focus on reducing leverage and improving the company's net debt position.
- How does debt repayments compare across companies?
- Standard across all capital-intensive industries; peers with high debt loads will show higher repayment activity.